Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma
Clinicopathological characterization and oncologic outcomes of metastatic small renal masses...
Read More
Kidney Cancer Journal
Clinical outcomes of patients treated with local therapies with oligometastatic renal cell carcinoma (mRCC).
Clinical outcomes of patients treated with local therapies with oligometastatic renal cell...
Read More
Clinical outcome of patients with metastatic Renal Cell Carcinoma (mRCC) progressing on front-line combination regimens that include checkpoint inhibitors
Clinical outcome of patients with metastatic Renal Cell Carcinoma (mRCC) progressing on front-line...
Read More
Clinical Activity of Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma
Clinical Activity of Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma Abstract...
Read More
Checkpoint Inhibitors in the Management of Renal Cell Carcinoma with Sarcomatoid Features
Checkpoint Inhibitors in the Management of Renal Cell Carcinoma with Sarcomatoid Features Abstract...
Read MoreExercise & Wellness
Mark A. Moyad, MD, MPH
University of Michigan
Ann Arbor, Michigan